SIDE EFFECTS – According to preliminary data from the annual report on drug use in the United States, carried out by health authorities and released on Wednesday, the overdose death rate in the country has never been so high. This increase in the number of victims is directly linked to the pandemic.
In the United States, the collateral damage of the pandemic did not take long to surface. In 2020, the country experienced a record of overdose deaths, driven by isolation, precariousness or even smaller budgets allocated to associations helping drug addicts. Those deaths jumped 30% to 93,000, according to preliminary statistics from the Centers for Disease Control and Prevention (CDC), released on Wednesday. While this overdose death rate has been rising steadily since 2019, it is nevertheless the largest increase recorded in a single year.
All the info on
Coronavirus: the pandemic that is shaking the planet
At what stage is the epidemic, department by department?
At the heart of this record, the CDC reports other unprecedented numbers: highest number of drug overdose deaths in a year; the highest number of deaths from opioid overdoses; the highest number of deaths from synthetic opioids, known as fentanyls; the highest number of deaths from overdoses of stimulants, such as methamphetamine.
Social distancing, or the forced isolation of drug addicts
These overdoses peaked in the spring of 2020, in the midst of the pandemic’s most severe economic downturn and lockdown. José Benitez, the executive director of the prevention center in Philadelphia (Pennsylvania), testifies to this period in the New York Times.He says in particular that it was not uncommon for two patients followed in his establishment, which notably provides help to drug addicts, die every week.
For him, public health warnings against the Covid concerning social distancing are not unrelated to these deaths. Drug users are generally encouraged to take them in the presence of other people, so that they can revive them in the event of an overdose. The number of appointments in his center, he fell by 20% during the health crisis. Part of the funding allocated to them was also diverted to support Covid services.
Young people and communities of color most affected
If the Covid-19 has taken the lives of the elderly, the majority of these overdoses have particularly affected young people. The 93,000 deaths linked to drug overuse have cost Americans an estimated 3.5 million years of life, according to an analysis by the New York Times. In comparison, deaths from coronaviruses in 2020 were responsible for around 5.5 million years of life.
Black and Hispanic populations were also more affected than whites. “The pandemic has been far more disruptive for communities of color than for white communities”, affirms to the American daily Joshua Sharfstein, vice-dean of the school of public health Johns Hopkins Bloomberg by relying on the rates of mortality, injection, unemployment and precariousness in these populations. “So many of the consequences of the pandemic have hit communities of color harder. So it is not illogical that overdoses should do the same.”
An increase in drug use globally
On June 24, a report by the United Nations Office on Drugs and Crime (UNODC) reported a general increase in drug consumption around the world, and in particular cannabis and drugs such as tramadol, benzodiazepines or barbiturates. The use of cocaine or MDMA, usually consumed during festive events, has however decreased due to lockdowns, curfews and the closing of nightclubs, measures adopted by many countries. In total, some 275 million people around the world used drugs in 2020, up from 269 million in 2018.
“Opioid crisis” in the United States: what are we talking about?
VIDEO – Paused during confinement, drug trafficking resumes again
According to the report’s authors, 42% of healthcare professionals surveyed in 77 countries said cannabis use increased as a result of environmental stress, decreased social interactions, or boredom. In France, a third of cannabis users have increased their consumption. The UNODC also reports an increase in the consumption of cocaine and MDMA during the summer months of 2020 in France, visible through analyzes of wastewater.
On the same subject
The most read articles
LIVE – Floods: more than 1,300 people missing in Germany
Covid-19: what we know about the side effects of vaccines
Covid-19: the effectiveness of the vaccine now quantified
Éric Dupond-Moretti indicted: the opposition divided on a possible resignation of the minister
LIVE – Covid-19: nearly 880,000 vaccine injections in 24 hours, a record
defends the ambition of information free, verified and accessible to all thanks to the income of the publicity .
To help us maintain this free service you can “change your choice” and accept all cookies.
Over 5,000 Italians are affected by biliary tract cancers every year. 25% of diagnoses are random, half of cases develop for no apparent reason with no or late symptoms. And the localization is in difficult or hidden locations, such as inside or near the liver and gallbladder, with the possibility of doubling the volume in just 28 days compared to 190 days for breast cancer. These are some alarming aspects mentioned by Ropi (Italian Oncology Patients Network) which will be explored in the new Notebook which will be presented with a webinar on Monday 5 July.
Early diagnosis of these types of tumors is ‘fortuitous’ (20-25% of cases) and often depends on an ultrasound of the liver or abdomen performed for other causes. In about 50% of cases, the disease develops for no apparent reason. Research today offers new and important therapeutic opportunities: at least four latest generation drugs that target two genes responsible for the disease, IDH1 and FGFR2, and capable of increasing survival, improving the quality of life and reducing mortality by about 30%.
“Tumors of the biliary tract including gallbladder tumors and cholangiocarcinomas – explains the president of the Aiom Foundation, Stefania Gori – have different manifestations depending on the location and type of growth. In most cases they are asymptomatic in the initial phase and then develop in case of intrahepatic or extrahepatic cholangiocarcinoma (inside or outside the liver). This is why this Ropi Notebook is particularly important “, explains the president of the Aiom Foundation, Stefania Gori. “In recent years – adds Giovanni Brandi, medical oncologist at the Sant’Orsola Malpighi University Hospital of Bologna and Founder of the Gico Group (Italian Cholangiocarcinoma Group) – the diagnosis of intrahepatic cholangiocarcinomas is more frequent. A growth presumably attributable to geographical differences and temporal changes in the risk factors associated with the different forms of cancer “. “Our Association – concludes Paolo Leonardi, President of APIC (Association of Italian Patients with Cholangiocarcinoma) – has collected on the website (www.apicinfo.it) useful information on the disease and above all on accredited and highly specialized centers to contact” .
Aducanumab is the new remedy, the first ever Alzheimer can slow down. It is approved in the USA – and highly controversial.
Alzheimer’s drug approved in the USA – will we soon?
For Alzheimer’s sufferers and their relatives it is the only glimmer of hope in a desperate situation, for the manufacturer Biogen a billion dollar business – for many scientists and doctors, aducanumab is one thing above all: too little researched.
Nevertheless, the American Food and Drug Safety Authority (FDA) approved the novel active ingredient against Alzheimer’s at the beginning of June 2021.
A medical sensation: The active ingredient aducanumab or Aduhelm (US brand name) is the first drug ever to fight the disease itself. In the case of Alzheimer’s dementia, only the symptoms, if at all, could be alleviated with medication. Now, in theory, aducanumab should slow down the progression of mental decline in every Alzheimer’s patient, regardless of the stage. A medicine revolution? It’s very controversial. This is not the only reason why it will take some time before the drug comes onto the market in Germany – if at all. Read here how the new Alzheimer’s drug works, everything about the research situation, and what makes aducanumab approval so problematic
Register now for the picture of the woman newsletter
Our best news, puzzles, recipes and guides of the week for you by email and free of charge.
How Alzheimer’s occurs and how aducanumab is supposed to stop it
Aducanumab is a monoclonal antibody, which means that it works in the body like a kind of vaccination. The goal of a normal vaccination is to produce antibodies that work against a pathogen. Alzheimer’s is not about viruses or bacteria that should be fought, but the goal is something else – the protein beta-amyloid. How Alzheimer’s occurs and why beta amyloid plays a major role in it:
To make the human brain so efficient, more than 100 billion nerve cells work together, constantly processing information and stimuli. So that the network works, the nerve cells are connected via contact points, so-called synapses. The exchange takes place via the synapses through messenger substances. You are the first to be affected by Alzheimer’s, so that the communication between the nerve cells no longer works properly – the first disturbances appear, e.g. increased forgetfulness, concentration and orientation problems.
➔ This is how you can recognize the first signs of Alzheimer’s disease and act!
In the further course of the disease, nerve cells die completely, they are irretrievably lost. This leads to drastic symptoms, which can be very individual depending on the Alzheimer’s patient – also how quickly the disease progresses is very different. Alzheimer’s has four stages that can span up to 20 years. In the third and fourth stages, those affected often suffer from:
Loss of short-term memory and long-term memory disruption, e.g. sudden memories from childhood.
Loss of ability to recognize faces, including those of close relatives.
Disturbed sense of time and disturbed day / night rhythm.
Disorientation, nervousness, distrust, often the need to run away.
Talking, swallowing, and moving become difficult or impossible.
In short: the brain gradually stops functioning. But what destroys this once powerful organ? Despite intensive research, it is still not known exactly why some people develop Alzheimer’s and others do not. What is certain, however, is that two factors lead to the destruction of nerve cells: the protein beta-amyloid and the protein component tau protein.
Beta amyloid occurs naturally in the brain and is completely harmless in itself. Beta amyloid arises from a biochemical reaction. In Alzheimer’s disease, this process changes, so that defective beta-amyloid proteins are created. They accumulate and clump, thereby forming indissoluble deposits between the nerve cells, the plaques. In addition, there is a modified tau protein, i.e. a protein building block, in the nerve cells.
Tau proteins help move nutrients from one cell to another. In Alzheimer’s disease, the tau protein changes so that it is deposited in the nerve cell, causing it to lose its shape and break down.
Alzheimer’s goes back to the fact that nerve cells in the brain are damaged by protein deposits. This is where aducanumab comes in. The active ingredient reduces the plaques from the protein beta-amyloid in the brain, as studies clearly show. There is great disagreement about everything else.
Why the approval of the Alzheimer’s drug is so controversial
It was an unusual move by the US FDA – they have now granted aducanumab marketing authorization, but only on condition that further research takes place. Normally, all studies and tests with patients must be completed before a new drug can come onto the market. However, when it comes to treating Alzheimer’s, the situation is complex, not to say desperate. It is better to use a remedy that might just prevent patients from losing weight further than to have no remedy at all, so the argument of patient representatives and Alzheimer’s relatives. In addition, precious time should not be wasted. Because even aducanumab is not able to cure Alzheimer’s or reverse the damage, the disease can only be prevented from progressing – maybe.
How effective aducanumab really is is highly controversial and cannot yet be determined with certainty. Because it’s not clear whether a decrease in beta amyloid is really enough to stop Alzheimer’s disease. The clinical tests by the manufacturer Biogen do not show a clear picture, but rather two contradicting phase 3 studies. Phase 3 of approval studies is an examination with a large number of patients, one group of whom receives the new drug and another group is treated as usual or receives a placebo preparation. The comparison of the results should show whether the remedy is effective and also what side effects occur. In the case of aducanumab, a phase 3 study showed that the active ingredient could slightly slow down the mental decline in Alzheimer’s patients. Another study, however, showed no clear effect. As a result, the studies were stopped prematurely because aducanumab did not appear to have any benefits for those affected – it was unethical to continue exposing people to a novel drug with potential side effects if it does not help anyway.
However, manufacturer Biogen then stated that further data had been evaluated and found that a particularly high dose of aducanumab had positive effects after all. The decline in mental abilities and memory is said to have been slowed down by about 22 percent. This means that the mental decline, calculated over a period of one and a half years, could be postponed by about four months. After many debates from various scientific committees, the FDA has now decided to grant approval in order to give Alzheimer’s patients and their relatives the chance of more time in better health.
How do you rate the Alzheimer’s drug in Germany?
In this country people are a lot more cautious about the potential of aducanumab. The assessment of the Alzheimer Research Initiative eV, which promotes education and independent scientific research on Alzheimer’s:
“We welcome the decision of the FDA to approve the Alzheimer’s active ingredient aducanumab on the condition that the manufacturer Biogen submits another study on the effectiveness of the drug. (…) The approval shouldn’t raise false hopes. It does not cure the disease, it slows down the loss of memory to a small extent. For patients in a very early stage of the disease, this can temporarily noticeably stabilize their cognitive abilities and quality of life. “
So it doesn’t help, doesn’t it hurt? Unfortunately, no. Because even if Alzheimer’s patients are people at the end of their life, the possible side effects of aducanumab must not be forgotten. “The effect is offset by serious side effects and extensive and close-knit medical supervision. One side effect of the active ingredient is brain swelling, which can lead to cerebral hemorrhage undetected. Therefore, participants in the approval studies were examined at regular intervals with imaging procedures such as MRI the dose was suspended. Such accompanying examinations would also have to be carried out regularly on patients, “the Alzheimer Research Initiative points out.
Treatment would not be done with the administration of the drug, accompanying examinations could mean further stress, especially for Alzheimer’s patients, and make acceptance more difficult. Another problem is that although aducanumab can theoretically be used in any stage of Alzheimer’s disease, those affected often no longer have the mental abilities to actively choose it.
What will happen to the patient studies on aducanumab?
Aducanumab can currently only be prescribed in the USA, and there are no clinical studies on the active ingredient in this country that patients can participate in. The European Medicines Agency (EMA) will likely decide towards the end of the year whether aducanumab should be approved in the EU. The manufacturer Biogen had submitted an application for this.
The EMA first decides on approval on the basis of study data from the USA. There, Biogen was obliged to carry out additional studies after the market launch, which should clearly demonstrate how much aducanumab improves cognitive abilities. The company has nine years to do this. An approach that worries many scientists. They fear that it will be very difficult to find participants for a placebo-controlled study.
Why should Alzheimer’s patients get involved and maybe only get the dummy drug when they can simply get a prescription for aducanumab? Just one of the many stumbling blocks on the way to effective Alzheimer’s therapy. After all, two other active ingredients are currently in the trial phase and could come onto the market within the next few years, perhaps with greater effectiveness. The Alzheimer’s Research Initiative is cautiously optimistic about this new class of drugs:
“So far, there are no drugs in the drug therapy of Alzheimer’s disease that act on the basic mechanisms of the disease. The previous drugs stimulate brain performance, and side effects of the disease, such as depression, can be treated. Aduhelm takes action against this the protein deposits in the brain that are characteristic of Alzheimer’s disease. “
Anyway: Social contacts and exercise therapy help with depression in Alzheimer’s sufferers better than drugs, studies show.
Alzheimer’s is and will remain an incurable disease, which is one of the reasons why prevention is so important. After all, there is now some knowledge about measures that can protect you. This is especially important for women, because they are more often affected by Alzheimer’s disease.
You can find even more information on detection and prevention and also on the behavior of relatives on our Alzheimer’s topic page.
At the Alzheimer Research Initiative eV you will find explanations of the current state of Alzheimer’s research and medical background knowledge.
Burmese authorities on Saturday burned more than half a billion dollars in opium, heroin, methamphetamine and other drugs seized by police as a warning to traffickers who appear to have learned to circumvent travel restrictions due to Covid and resumed their traffic.
Read also :Drugs: from a simple fine to the fight against gangs, the police on all fronts
In Yangon, journalists could see a huge pile of bags of cannabis, next to others filled with small pink pills, and tables full of heroin and other various drugs, before the authorities set them on fire. sending a big black cloud over the neighborhood.
Similar operations also took place in the towns of Mandalay and Taunggyi, Shan State, burning $ 668 million worth of drugs, including 224 million methamphetamine tablets, police said. This operation took place on the occasion of the International Day against Drug Abuse and Trafficking.
The Golden Triangle of Drugs
Despite the restrictions due to Covid, it has recently been observed “a steady increase in the methamphetamine market in East and Southeast Asia“, Underlined the UN, which added to fear that this would increase further with the current difficulties of Burma.
Still according to the UN, Shan State in Burma remains the main source of this drug, which is often sent to foreign markets such as Australia and Japan in its more potent crystallized form. This state is part of the Golden Triangle, on the border of Burma, Laos and Thailand, center for decades of drug production in Southeast Asia.
To see also – Burma: Aung San Suu Kyi is “in good health” for his trial, according to his lawyer
A new drug treatment is able to stop the progression of the Alzheimer’s disease in the monkey brains. This was announced by research conducted by scientists from NYU Grossman School of Medicine in New York City. The drugs tested, CpG oligodeoxynucleotides (CpG ODN), induce immune defense cells to engulf the deformed proteins, beta amyloid plaques and tangles of tau, the accumulation of which kills neighboring brain cells causing debilitating disease. “The similarities in aging between the animals studied and our species give us hope that this therapy will also work in human patients,” said study author Henrieta Scholtzova of NYU Langone, reports the DailyMail.
Biogen, FDA ok for Alzheimer’s drug
In laboratory studies, older monkeys had up to 59% fewer beta-amyloid plaque deposits in their brains after CpG ODN treatment than untreated animals: the brains of treated animals had decreased tau levels. which can destroy nearby tissues when disease-related changes in its chemical structure cause it to attach to other cells. “Our results show that this therapy is an effective way of manipulating the immune system to slow neurodegeneration,” said study author Akash Patel, assistant researcher at the Center for Cognitive Neurology at NYU Langone Health.
Alzheimer’s, the first drug approved after 20 years: “Slows down the cognitive decline of the disease”
IMMUNE SYSTEM – Alzheimer’s disease is thought to be caused by the abnormal accumulation of proteins in and around brain cells, but it is not known exactly what causes this process to start. . The immune system is typically divided into two categories: “innate” and “adaptive”. The adaptive immune system intervenes after the innate immune system, which is the immediate response to a virus, or “first line of defense.” According to the researchers, a subset of immune cells in the innate immune system swallows and removes debris and toxins from body tissues along with invading microbes.
Previous studies have shown that these ‘immune keepers’ become sluggish as a person ages and fail to eliminate the toxins that cause neurodegeneration. Essentially, CpG ODN drugs are part of a class of innate immune regulators that accelerate these worn-out immune guardians.
Science & Health: ‘the microbiota, from Alzheimer’s to Covid’
I STUDY – In the course of the studythe research team studied 15 female squirrel monkeys between the ages of 17 and 19, ideal subjects for the study of Alzheimer’s, since virtually all squirrel monkeys naturally develop a form of disease-like neurodegeneration as they age. Human. Eight of the monkeys received a single dose of the drug once a month for two years, while the rest were given saline. At the end of the period, the scientists compared the behavior of the two groups by comparing brain tissue and blood samples for plaque deposits, tau protein levels, and evidence of inflammation.
New treatment stops progression of Alzheimer’s disease in monkey brains @nyulangone https://t.co/gLoIlAttQz
The drug would also bring cognitive benefits to the treated group of monkeys: subjected to a series of puzzles, the elderly monkeys who received the drug behaved similarly to young adult animals and much better than those of their age group. Not only that, the treatment would also lead to improvements in the animals’ abilities: the monkeys who took the drug were able to solve puzzles faster than their untreated peers.
A limitation of this study, however, is that the researchers only evaluated older monkeys that already showed significant signs of neurodegeneration. Only further tests on younger animals would allow them to evaluate the effectiveness of the treatment in the earlier stages of the disease. Now the research team plans to begin testing CpG ODN therapy on human patients with mild cognitive impairment or in the early stages of dementia and also intends to study this treatment in related neurodegenerative diseases.
below) // the var will be used by PaywallMeter to target the event on the correct pixel settings_testata.fbq_swg_promo = ‘556738118336305’; fbq (‘init’, header_settings.fbq_swg_promo); fbq (‘track’, ‘PageView’);
Recently carried out in-vitro tests show that the active ingredient carragelose, which is obtained from red algae and contained in the nasal spray algovir, can inactivate the alpha, beta and gamma variants of the SARS-CoV-2 virus . Even with the increasing prevalence of these virus mutants, algovir remains an effective option for minimizing the risk of Covid-19 infection in addition to general hygiene measures – also for pregnant women, breastfeeding women and children from one year old.
The Carragelose contained in the cold spray algovir is a natural active ingredient from red algae with a broad spectrum of action against a large number of viruses that cause respiratory diseases such as flu. Carragelose forms a protective film on the nasal lining and prevents the viruses from attaching to the cells in the lining. This reduces their multiplication and spread in the body. A number of previous laboratory studies with cell cultures [2,3,4,5] and a clinical study [6,7] were able to show that Carragelose also inactivates the SARS-CoV-2 virus in the wild-type variant.
New in vitro tests now confirm that this also applies to the alpha (B.1.1.7), beta (B.1.351) and gamma (P.1 *) mutants with similar effectiveness . This is relevant insofar as the virus variants now clearly determine what happens in the pandemic. According to the Robert Koch Institute, the alpha variant first discovered in Great Britain has long dominated in Germany. Their share in samples tested for SARS-CoV-2 was already almost 92 percent at the beginning of May . The carragelose-containing nasal spray algovir (from the pharmacy) remains an option that goes beyond general hygiene measures in order to minimize the risk of Covid-19 infection.
[*] Full Scientific Name of P1 (L18F T20N P26S D138Y R190S K417T E484K N501Y D614G H655Y T1027I)
 Marinomed AG. Marinomed Biotech AG publishes positive data on the effectiveness of Carragelose against SARS-CoV-2 mutations.
https://ots.de/3UZHfi, last accessed on April 28, 2021.
 Kumbhar, Popat S.; Pandya, Anjali K.; Manjappa, Arehalli S.; Disouza, John I.; Patravale, Vandana B. Carbohydrates-based diagnosis, prophylaxis and treatment of infectious diseases: Special emphasis on COVID-19. Carbohydrate Polymer Technologies and Applications ; 2:100052, 2021. https://www.sciencedirect.com/science/article/pii/S2590049821000102.
 Jiang X, Li Z, Young DJ, Liu M, Wu C, Wu YL, Loh XJ. Toward the prevention of coronavirus infection: what role can polymers play? Mater Today Adv. 2021 Jun;10:100140. doi: 10.1016/j.mtadv.2021.100140.
 Bansal S, Jonsson CB, Taylor SL et al. Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture. bioRxiv preprint 2020, doi: DOI 10.1101/2020.08.19.225854.
 Morokutti-Kurz M, Fröba M, Graf P, Große M, Grassauer A, et al. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. PLOS ONE 2021;16(2):e0237480. DOI 10.1371/journal.pone.0237480.
 ICT MILSTEIN, CONICET- Pablo Cassará Foundation. The efficacy of nasal spray with carrageenan for the prevention of COVID-19 has yielded positive results – CARR Preliminary Report, 02/18/2021. Buenos Aires, Argentinien: ICT MILSTEIN. Abgerufen am: 10.06.2021. https://ots.de/xHUUl5.
 NIH ClinicalTrials.gov. Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease (CARR-COV-02), ClinicalTrials.gov Identifier: NCT04521322. Letzter Zugriff: 10.06.2021. ClinicalTrials.gov – NCT04521322.
Press contact Dr. Andreas Erber HERMES ARZNEIMITTEL GMBH Georg-Kalb-Strasse 5 – 8 82049 Pullach i. Isartal Tel. +49 (0)89-79 102-138 Fax +49 (0)89-79 102-139 Email: email@example.com www.hermes-arzneimittel.com
Original content from: Hermes Arzneimittel GmbH, transmitted by news aktuell
(ANSA) – ROME, JUNE 09 – A new drug promises positive effects and an increase in survival against chronic lymphocytic leukemia without worsening the disease. This is what emerges from the final results of the phase III Elevate-Rr study that demonstrated progression-free survival and fewer atrial fibrillation events with the use of acalabrutinib compared to the currently used drug Ibrutinib. “One of the major obstacles to treating patients with chronic lymphocytic leukemia, patients who are typically diagnosed after age 70 and often have one or more comorbidities, is finding effective and tolerated treatment options for long-term disease management without having to interrupt the therapeutic path – explains Paolo Ghia, professor of Medical Oncology at the Vita-Salute San Raffaele University – The results of the Elevate-Rr study confirm the potential of acalabrutinib in terms of disease control for patients with chronic lymphatic leukemia who they have already faced a first line of treatment “. “Having an effective and better tolerated treatment option is excellent news for clinicians and for the more than 3,000 patients in Italy who receive this type of diagnosis every year,” he adds.
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults, with an estimated 191,000 new cases worldwide. (HANDLE).
You go, invest in money, then you do whatever you want to do. You know, Sülü has a relative in Ankara, this municipality accent of his works. He has become a giant, ministers and general managers direct them all. The system in the municipalities I am talking about. Now that you invested the money there, you will say that the money did not go to the mayor. What is he doing? There is a job worth 100 thousand liras, he says to his most trusted friend, ‘make out an invoice of 1 million’.
There is such a ridiculous thing as giving the job to the person he wants, and you (youth) you will remove. The best bidder should win the contract. Then he takes the 1 million lira job but does it for 100 thousand liras. He gives him 100 thousand liras, and if 100 thousand taxes etc., he takes the remaining 800 thousand liras without bones and pockets it. Look, I’m not kidding. And why aren’t any police under surveillance, why are they not punished, they are acquitted in the end? Because the system is on it.
$600 million without bones without doing any work
I will explain how the subcontractor system works. These can be changed with one simple move. A person has a weakness for his wife and child, they can influence him and direct you. You will set up the system. You’ll make me do the lion hunt, and I’ll tell you.
You always say, 5’li çete, gang of ten, just because they’re giving them the contract. They are getting the tender for 1 billion dollars, do you think they have workers, no, they don’t. There is a subcontractor system. They outsource the work to subcontractors. It subcontracts 400 thousand million dollars, $600 million boneless on this side.
The subcontractor also has a subcontractor
Subcontractors also have subcontractors. Honestly, disgrace, comedy. This is how the whole system works. What is that subcontractor doing? Lastly, that subcontractor has a six, they are the owners of trucks and such, they also find their way and find the reward of their labor. But the money in the middle is neither truck, nor this nor that. You will say that you have removed the subcontractor system. You will open the tender, he will enter the tender even over the phone, he will prepare all the documents. If the subcontractor can do this, why is it taking 200 million dollars from the state? Where is this money going? When you keep this money, the minimum wage will be 10 thousand.
If one of them is wrong, I will cut my hand
What will you do for me? There are honest journalists, I don’t talk in vain, believe me if I’m talking about something. I wouldn’t embarrass me to you or you to anyone else. They say, ‘Everything Sedat Peker said has started to come true’. If one of them is wrong, I say I will cut my hand, don’t you understand?
You journalists, the climate of fear is broken though. Encourage journalists to overcome that climate of fear, but honest ones. When you give them courage, there are hard-hearted types in the opposition parties, when you give them enthusiasm and pressure, we will not vote, they will go once. If only the government had opened it, everything would come out.
Pointing out that there is an atmosphere of peace and trust in every corner of Turkey, Soylu emphasized that this was achieved with the strong leadership of President Recep Tayyip Erdoğan and the support and will of MHP Chairman Devlet Bahçeli.
“BEAUTIFUL DAYS ARE COMING AHEAD”
Pointing out that the country is going through a difficult period and people lost their relatives during the fight against Kovid-19, Soylu said:
“We faced a calamity, an epidemic and a disease. We overcome it, but thanks to your patience, dignity and fortitude. Street incidents took place in many developed countries of the world, people made a demonstration, but this noble and beautiful person of Anatolia, the state, did whatever he said. Harmony , by agreement… May Allah be pleased with him, he made great sacrifices in overcoming the epidemic. Mothers, teachers, children, headmen, shopkeepers, business people, farmers, everyone?. Mask piracy was carried out in the world. Big countries stole each other’s masks. They plundered the markets. There is no such thing here. Nothing happened. This is due to the nobility of the nation. This is due to their respect and love for each other. Good days are coming, we all persevered together, I hope we have reduced this epidemic together. Hopefully, vaccines are also coming gradually to completely eradicate the epidemic. Let me tell you something, there are many others. If you will see, my country’s economy will take such an attack as of July, they will be jealous. Things will leap and grow so that the Germany, France, England, Italy, and especially the meddling USA around us will crack and explode.”
“You have defeated those who do not want my country to grow and become rich with a 50 gram ballot”
Emphasizing that Turkey has a strong leader who knows the world, country and nation for 19 years, Soylu continued as follows:
“They have brought a lot of troubles and troubles to this country. In order to devalue the vote you will cast tomorrow, you will be asked, ‘Who are you to rule this country?’. Praise God to those who say, ‘You are the people, you are not what we want, we don’t like you’, you teach with a 50 gram ballot paper. You defeated the 1971 memorandum and the 1980 coup with it. You defeated those who messed with our faith, clothes and identity on February 28. You stood tall in the AK Party closure case. They were scared, frightened, cowed, could not take a step. Your 50-gram ballot paper was defeated. They were supposed to be environmentalists, the Gezi events You have defeated those who do not want Turkey to start and face more costs while Turkey’s interest rate is 4.5, so that the people of this country do not find peace, do not grow and get richer, do not want Turkey to be a great and strong, my country to grow and prosper, with a 50 gram ballot.”
“THE NUMBER OF TERRORISTS, WHICH WAS APPROXIMATELY 15-20 THOUSAND IN TURKEY, HAS DROPPED TO 250”
Drawing attention to the success in the fight against terrorism in the country, Soylu said:
“On the way here, the Gendarmerie General Commander called, 3 more terrorists left in Van Başkale. We will produce, our children will study, they will have jobs. There will be tourists all over our country. People will plow their lands. Everything will happen. They will also scare and threaten mothers’ children. They will take them to the mountain. They took the 9-year-old hafiz children from their mothers and brought them to the mountain. If we don’t hold them accountable, our necks will be bowed down in this world and the next. How did the mothers of Diyarbakir make the HDP surrender. They don’t know what the hearts of mothers are. Around 15-20 thousand in Turkey The number of terrorists, who are terrorists, has dropped to 250. It will decrease even more. 5 thousand 500 people were joining the terrorist organization in 1 year. Now 6 months have passed, 4 of them from abroad. We will reset it all together. All parts of our beautiful Turkey are at peace. ”
Stating that significant achievements have been achieved with stability, strong leadership and understanding of government, Soylu said, “Now we are in Hakurk, Asiyan, Metina and Zap in northern Iraq. We do not give up on terrorism with our crescent and star flag.” he said.
“RIGHT NOW THERE ARE 88 THOUSAND PEOPLE FROM DRUGS”
Stating that they are also fighting against drugs strongly, Soylu reminded that they achieved the biggest seizures in the history of the Republic.
Underlining that they will not allow them to poison children and that they will not give up in the fight against drugs, Soylu said, “There are 88 thousand people in prison right now. We are fighting a big fight. We take 3,500-4 thousand people into custody every week. A significant part of the insiders are dealers. “We’re pushing it off the market. But someone is offended.” used his statements.